Medbridge backs biotech company VG Life Sciences
VG Life Sciences said Wednesday that it has closed $2,235,000 from MedBridge Venture Fund. Based in Santa Barbara, Calif., VG Life Sciences (formerly named Viral Genetics), is a biotechnology company focused on discovering and developing treatments for cancer, infectious disease, and inflammatory, autoimmune disorders.
2 October 2013•2 mins read
